カテゴリー： Grand View Research, 世界, 医療/バイオ

世界のグライコミックス市場2023-2030：製品別（酵素、キット、試薬、機器）、用途別（創薬・開発、診断）、最終用途別、地域別

◆英語タイトル：Glycomics Market Size, Share & Trends Analysis Report By Product (Enzymes, Kits, Reagents, Instruments), By Application (Drug Discovery & Development, Diagnostics), By End Use, By Region, And Segment Forecasts, 2023 - 2030

Grand View Researchが発行した調査報告書（GRV23NVB023）◆商品コード：GRV23NVB023
◆発行会社（リサーチ会社）：Grand View Research
◆発行日：2023年10月17日
◆ページ数：180
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後3営業日）
◆調査対象地域：グローバル
◆産業分野：バイオテクノロジー
◆販売価格オプション（消費税別）
Single UserUSD5,950 ⇒換算￥904,400見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算￥1,056,400見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算￥1,360,400見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

グライコミックス市場の成長と動向

Grand View Research社の最新レポートによると、世界のグライコミックス市場規模は2030年までに49億2000万米ドルに達する見込みです。同市場は2023年から2030年の間に14.6%のCAGRを記録すると推定されています。様々な生物学的プロセスにおけるグライコミックスの重要な役割に起因する、グライコミックス分野における研究開発の増加が、世界市場を牽引すると予測されています。さらに、個別化医療に対する需要の高まりは、グライコミクスが糖鎖ベースの診断ソリューションの開発に重要な役割を果たしていることから、業界の成長をさらに後押ししています。

近年、グライコミクスは、さまざまな健康状態の早期発見と診断のための疾患特異的な糖鎖バイオマーカーの同定に有望視されています。糖鎖バイオマーカーの可能性は、ヘルスケアおよび診断業界からの関心を集めています。例えば、2021年11月にGlycoPath Inc.は、臨床および研究サンプルの糖プロテオーム解析用の糖鎖イメージングキットを発売しました。新たに発売されたキットは、組織イメージングから生体流体プロファイリングまで適用可能で、さまざまなプラットフォームに容易に適応できます。

技術の進歩もグライコミックス装置の高い需要に貢献しています。タンパク質の特性解析のような手順は、化学および生化学研究における質量分析（MS）、高速液体クロマトグラフィー（HPLC）、キャピラリー電気泳動（CE）のような高度な技術へと進化しています。これらの高度な技術により、迅速かつ正確な結果が得られます。現在利用可能なグライコミックス技術は標準化され、合理化されています。

さらに、糖鎖ベースの研究を支援する研究機関の増加が、近い将来の市場成長を促進すると予想される主な要因です。National Center for Biomedical Glycomics（NCBG）は、分析ゲノミクスのための技術とツールの普及と開発に注力しています。同センターの分析・技術研究開発プログラムでは、糖鎖ツール、糖鎖複合体、インフォマティクスの開発が行われています。さらに、国立がん研究センターは、がん研究のための糖鎖の構造と機能の研究を目的とする「Alliance of Glycobiologists for Cancer Research（がん研究のための糖鎖生物学者同盟）」で構成されています。

グライコミックス市場レポートハイライト

- 2022年の売上高シェアは酵素分野が29.2%で業界を席巻、これは糖鎖ベースの研究、診断、創薬における酵素の幅広い応用に起因します。

- 創薬および薬剤開発が市場最大の用途である一方、グリカンベースの診断薬開発に対する業界プレイヤーの関心の高まりにより、診断薬分野が最も急成長が見込まれています。

- 最終用途分野では、学術・研究機関分野が38.2%の収益シェアで市場を支配しています。高い収益成長は、研究センターによるグリカン構造データ解析の広範な採用や、トレーニングおよび教育目的でのグライコミクスへの嗜好の高まりによるものです。

- 2022年の世界市場は北米地域が39.1%の収益シェアで独占しました。同地域の高成長は、多数の研究機関の存在や政府による法整備などの要因に支配されています。

第1章. 調査方法・範囲
第2章. エグゼクティブサマリー
第3章. 市場変数・傾向・範囲
第4章. グライコミックスの世界市場：製品別分析
第5章. グライコミックスの世界市場：用途別分析
第7章. グライコミックスの世界市場：地域別分析
第8章. 競争状況

❖ レポートの目次 ❖

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.1.1. Segment Definition
1.1.1.1. Product Segment
1.1.1.2. Application Segment
1.1.1.3. End Use Segment
1.2. Regional Scope
1.3. Estimates and Forecast Timeline
1.4. Objective
1.4.1. Objective 1
1.4.2. Objective 2
1.4.3. Objective 3
1.5. Research Methodology
1.6. Information Procurement
1.6.1. Purchased Database
1.6.2. GVR’s Internal Database
1.6.3. Secondary Sources
1.6.4. Primary Research
1.7. Information or Data Analysis
1.7.1. Data Analysis Models
1.8. Market Formulation & Validation
1.9. Model Details
1.9.1. Commodity Flow Analysis
1.10. List of Secondary Sources
1.11. List of Abbreviations
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Increasing focus on glycomics and proteomics research
3.2.1.2. Rising R & D investments by pharmaceutical and biotechnology companies
3.2.1.3. Technological advancements
3.2.1.4. Increasing focus on developing alternative to animal testing
3.2.2. Market Restraint Analysis
3.2.2.1. High cost of glycomics instruments
3.2.2.2. Stringent government policies and regulations
3.3. Industry Analysis Tools
3.3.1. Porter’s Five Forces Analysis
3.3.2. PESTEL Analysis
3.3.3. COVID-19 Impact Analysis
Chapter 4. Product Business Analysis
4.1. Glycomics Market: Product Movement Analysis
4.2. Enzymes
4.2.1. Enzymes Market, 2018 – 2030 (USD Million)
4.2.2. Glycosidases
4.2.2.1. Glycosidases Market, 2018 – 2030 (USD Million)
4.2.3. Glycosyltransferases
4.2.3.1. Glycosyltransferases Market, 2018 – 2030 (USD Million)
4.2.4. Neuraminidases
4.2.4.1. Neuraminidases Market, 2018 – 2030 (USD Million)
4.2.5. Sialyltransferases
4.2.5.1. Sialyltransferases Market, 2018 – 2030 (USD Million)
4.2.6. Others
4.2.6.1. Others Market, 2018 – 2030 (USD Million)
4.3. Kits
4.3.1. Kits Market, 2018 – 2030 (USD Million)
4.3.2. Glycan labeling kits
4.3.2.1. Glycan labeling kits Market, 2018 – 2030 (USD Million)
4.3.3. Glycan purification kits
4.3.3.1. Glycan purification kits Market, 2018 – 2030 (USD Million)
4.3.4. Glycan release kits
4.3.4.1. Glycan release kits Market, 2018 – 2030 (USD Million)
4.3.5. Other glycomics kits
4.3.5.1. Other glycomics kits Market, 2018 – 2030 (USD Million)
4.4. Reagents
4.4.1. Reagents Market, 2018 – 2030 (USD Million)
4.4.2. Glycoproteins
4.4.2.1. Glycoproteins Market, 2018 – 2030 (USD Million)
4.4.3. Monosaccharides
4.4.3.1. Monosaccharides Market, 2018 – 2030 (USD Million)
4.4.4. Oligosaccharides
4.4.4.1. Oligosaccharides Market, 2018 – 2030 (USD Million)
4.4.5. Other reagents
4.4.5.1. Other reagents Market, 2018 – 2030 (USD Million)
4.5. Instruments
4.5.1. Instruments Market, 2018 – 2030 (USD Million)
4.5.2. Mass spectrometers
4.5.2.1. Mass spectrometers Market, 2018 – 2030 (USD Million)
4.5.3. HPLC
4.5.3.1. HPLC Market, 2018 – 2030 (USD Million)
4.5.4. MALDI-TOF
4.5.4.1. MALDI-TOF Market, 2018 – 2030 (USD Million)
4.5.5. Array systems
4.5.5.1. Array systems Market, 2018 – 2030 (USD Million)
4.5.6. Others
4.5.6.1. Others Market, 2018 – 2030 (USD Million)
Chapter 5. Application Business Analysis
5.1. Glycomics Market: Application Movement Analysis
5.2. Drug Discovery & Development
5.2.1. Drug Discovery & Development Market, 2018 – 2030 (USD Million)
5.3. Diagnostics
5.3.1. Diagnostics Market, 2018 – 2030 (USD Million)
5.4. Others
5.4.1. Others Market, 2018 – 2030 (USD Million)
Chapter 6. End Use Business Analysis
6.1. Glycomics Market: End Use Movement Analysis
6.2. Pharmaceutical & Biotechnology Companies
6.2.1. Pharmaceutical & Biotechnology Companies Market, 2018 – 2030 (USD Million)
6.3. Academic & Research Institutes
6.3.1. Academic & Research Institutes Market, 2018 – 2030 (USD Million)
6.4. Biopharmaceutical Companies
6.4.1. Biopharmaceutical Companies Market, 2018 – 2030 (USD Million)
6.5. CROs
6.5.1. CROs Market, 2018 – 2030 (USD Million)
Chapter 7. Regional Business Analysis
7.1. Glycomics Market Share By Region, 2022 & 2030
7.2. North America
7.2.1. North America Glycomics Market, 2018 – 2030 (USD Million)
7.2.2. U.S.
7.2.2.1. Key Country Dynamics
7.2.2.2. Target Disease Prevalence
7.2.2.3. Competitive Scenario
7.2.2.4. U.S. Glycomics Market, 2018 – 2030 (USD Million)
7.2.3. Canada
7.2.3.1. Key Country Dynamics
7.2.3.2. Target Disease Prevalence
7.2.3.3. Competitive Scenario
7.2.3.4. Canada Glycomics Market, 2018 – 2030 (USD Million)
7.3. Europe
7.3.1. Europe Glycomics Market, 2018 – 2030 (USD Million)
7.3.2. UK
7.3.2.1. Key Country Dynamics
7.3.2.2. Target Disease Prevalence
7.3.2.3. Competitive Scenario
7.3.2.4. UK Glycomics Market, 2018 – 2030 (USD Million)
7.3.3. Germany
7.3.3.1. Key Country Dynamics
7.3.3.2. Target Disease Prevalence
7.3.3.3. Competitive Scenario
7.3.3.4. Germany Glycomics Market, 2018 – 2030 (USD Million)
7.3.4. France
7.3.4.1. Key Country Dynamics
7.3.4.2. Target Disease Prevalence
7.3.4.3. Competitive Scenario
7.3.4.4. France Glycomics Market, 2018 – 2030 (USD Million)
7.3.5. Italy
7.3.5.1. Key Country Dynamics
7.3.5.2. Target Disease Prevalence
7.3.5.3. Competitive Scenario
7.3.5.4. Italy Glycomics Market, 2018 – 2030 (USD Million)
7.3.6. Spain
7.3.6.1. Key Country Dynamics
7.3.6.2. Target Disease Prevalence
7.3.6.3. Competitive Scenario
7.3.6.4. Spain Glycomics Market, 2018 – 2030 (USD Million)
7.3.7. Denmark
7.3.7.1. Key Country Dynamics
7.3.7.2. Target Disease Prevalence
7.3.7.3. Competitive Scenario
7.3.7.4. Denmark Glycomics Market, 2018 – 2030 (USD Million)
7.3.8. Sweden
7.3.8.1. Key Country Dynamics
7.3.8.2. Target Disease Prevalence
7.3.8.3. Competitive Scenario
7.3.8.4. Sweden Glycomics Market, 2018 – 2030 (USD Million)
7.3.9. Norway
7.3.9.1. Key Country Dynamics
7.3.9.2. Target Disease Prevalence
7.3.9.3. Competitive Scenario
7.3.9.4. Norway Glycomics Market, 2018 – 2030 (USD Million)
7.4. Asia Pacific
7.4.1. Asia Pacific Glycomics Market, 2018 – 2030 (USD Million)
7.4.2. Japan
7.4.2.1. Key Country Dynamics
7.4.2.2. Target Disease Prevalence
7.4.2.3. Competitive Scenario
7.4.2.4. Japan Glycomics Market, 2018 – 2030 (USD Million)
7.4.3. China
7.4.3.1. Key Country Dynamics
7.4.3.2. Target Disease Prevalence
7.4.3.3. Competitive Scenario
7.4.3.4. China Glycomics Market, 2018 – 2030 (USD Million)
7.4.4. India
7.4.4.1. Key Country Dynamics
7.4.4.2. Target Disease Prevalence
7.4.4.3. Competitive Scenario
7.4.4.4. India Glycomics Market, 2018 – 2030 (USD Million)
7.4.5. Australia
7.4.5.1. Key Country Dynamics
7.4.5.2. Target Disease Prevalence
7.4.5.3. Competitive Scenario
7.4.5.4. Australia Glycomics Market, 2018 – 2030 (USD Million)
7.4.6. Thailand
7.4.6.1. Key Country Dynamics
7.4.6.2. Target Disease Prevalence
7.4.6.3. Competitive Scenario
7.4.6.4. Thailand Glycomics Market, 2018 – 2030 (USD Million)
7.4.7. South Korea
7.4.7.1. Key Country Dynamics
7.4.7.2. Target Disease Prevalence
7.4.7.3. Competitive Scenario
7.4.7.4. South Korea Glycomics Market, 2018 – 2030 (USD Million)
7.5. Latin America
7.5.1. Latin America Glycomics Market, 2018 – 2030 (USD Million)
7.5.2. Brazil
7.5.2.1. Key Country Dynamics
7.5.2.2. Target Disease Prevalence
7.5.2.3. Competitive Scenario
7.5.2.4. Brazil Glycomics Market, 2018 – 2030 (USD Million)
7.5.3. Mexico
7.5.3.1. Key Country Dynamics
7.5.3.2. Target Disease Prevalence
7.5.3.3. Competitive Scenario
7.5.3.4. Mexico Glycomics Market, 2018 – 2030 (USD Million)
7.5.4. Argentina
7.5.4.1. Key Country Dynamics
7.5.4.2. Target Disease Prevalence
7.5.4.3. Competitive Scenario
7.5.4.4. Argentina Glycomics Market, 2018 – 2030 (USD Million)
7.6. MEA
7.6.1. MEA Glycomics Market, 2018 – 2030 (USD Million)
7.6.2. South Africa
7.6.2.1. Key Country Dynamics
7.6.2.2. Target Disease Prevalence
7.6.2.3. Competitive Scenario
7.6.2.4. South Africa Glycomics Market, 2018 – 2030 (USD Million)
7.6.3. Saudi Arabia
7.6.3.1. Key Country Dynamics
7.6.3.2. Target Disease Prevalence
7.6.3.3. Competitive Scenario
7.6.3.4. Saudi Arabia Glycomics Market, 2018 – 2030 (USD Million)
7.6.4. UAE
7.6.4.1. Key Country Dynamics
7.6.4.2. Target Disease Prevalence
7.6.4.3. Competitive Scenario
7.6.4.4. UAE Glycomics Market, 2018 – 2030 (USD Million)
7.6.5. Kuwait
7.6.5.1. Key Country Dynamics
7.6.5.2. Target Disease Prevalence
7.6.5.3. Competitive Scenario
7.6.5.4. Kuwait Glycomics Market, 2018 – 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Company Categorization
8.2. Strategy Mapping
8.3. Company Market Share/Position Analysis, 2022
8.4. Company Profiles/Listing
8.4.1. Thermo Fisher Scientific, Inc
8.4.1.1. Overview
8.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.1.3. Product Benchmarking
8.4.1.4. Strategic Initiatives
8.4.2. Merck KGaA
8.4.2.1. Overview
8.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.2.3. Product Benchmarking
8.4.2.4. Strategic Initiatives
8.4.3. Agilent Technologies Inc.
8.4.3.1. Overview
8.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.3.3. Product Benchmarking
8.4.3.4. Strategic Initiatives
8.4.4. Bruker
8.4.4.1. Overview
8.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.4.3. Product Benchmarking
8.4.4.4. Strategic Initiatives
8.4.5. New England Biolabs
8.4.5.1. Overview
8.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.5.3. Product Benchmarking
8.4.5.4. Strategic Initiatives
8.4.6. Shimadzu Corporation
8.4.6.1. Overview
8.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.6.3. Product Benchmarking
8.4.6.4. Strategic Initiatives
8.4.7. Waters Corporation
8.4.7.1. Overview
8.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.7.3. Product Benchmarking
8.4.7.4. Strategic Initiatives
8.4.8. Takara Bio Inc
8.4.8.1. Overview
8.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.8.3. Product Benchmarking
8.4.8.4. Strategic Initiatives
8.4.9. Asparia Glycomics
8.4.9.1. Overview
8.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.9.3. Product Benchmarking
8.4.9.4. Strategic Initiatives
8.4.10. RayBiotech Life, Inc.
8.4.10.1. Overview
8.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.10.3. Product Benchmarking
8.4.10.4. Strategic Initiatives

List of Tables

TABLE 1 List of Secondary Sources
TABLE 2 List of Abbreviations
TABLE 3 Regulatory Framework
TABLE 4 Global Glycomics Market, By Product, 2018 - 2030 (USD Million)
TABLE 5 Global Glycomics Market, By Application, 2018 - 2030 (USD Million)
TABLE 6 Global Glycomics Market, By End-Use, 2018 - 2030 (USD Million)
TABLE 7 Global Glycomics Market, By Region, 2018 - 2030 (USD Million)
TABLE 8 North America Glycomics Market, By Country, 2018 - 2030 (USD Million)
TABLE 9 North America Glycomics Market, By Product, 2018 - 2030 (USD Million)
TABLE 10 North America Glycomics Market, By Application, 2018 - 2030 (USD Million)
TABLE 11 North America Glycomics Market, By End-Use, 2018 - 2030 (USD Million)
TABLE 12 U.S. Glycomics Market, By Product, 2018 - 2030 (USD Million)
TABLE 13 U.S. Glycomics Market, By Application, 2018 - 2030 (USD Million)
TABLE 14 U.S. Glycomics Market, By End-Use, 2018 - 2030 (USD Million)
TABLE 15 Canada Glycomics Market, By Product, 2018 - 2030 (USD Million)
TABLE 16 Canada Glycomics Market, By Application, 2018 - 2030 (USD Million)
TABLE 17 Canada Glycomics Market, By End-Use, 2018 - 2030 (USD Million)
TABLE 18 Europe Glycomics Market, By Country, 2018 - 2030 (USD Million)
TABLE 19 Europe Glycomics Market, By Application, 2018 - 2030 (USD Million)
TABLE 20 Europe Glycomics Market, By Product, 2018 - 2030 (USD Million)
TABLE 21 Europe Glycomics Market, By End-Use, 2018 - 2030 (USD Million)
TABLE 22 UK Glycomics Market, By Product, 2018 - 2030 (USD Million)
TABLE 23 UK Glycomics Market, By Application, 2018 - 2030 (USD Million)
TABLE 24 UK Glycomics Market, By End-Use, 2018 - 2030 (USD Million),
TABLE 25 Germany Glycomics Market, By Product, 2018 - 2030 (USD Million)
TABLE 26 Germany Glycomics Market, By Application, 2018 - 2030 (USD Million)
TABLE 27 Germany Glycomics Market, By End-Use, 2018 - 2030 (USD Million)
TABLE 28 France Glycomics Market, By Product, 2018 - 2030 (USD Million)
TABLE 29 France Glycomics Market, By Application, 2018 - 2030 (USD Million)
TABLE 30 France Glycomics Market, By End-Use, 2018 - 2030 (USD Million)
TABLE 31 Spain Glycomics Market, By Product, 2018 - 2030 (USD Million)
TABLE 32 Spain Glycomics Market, By Application, 2018 - 2030 (USD Million)
TABLE 33 Spain Glycomics Market, By End-Use, 2018 - 2030 (USD Million)
TABLE 34 Italy Glycomics Market, By Product, 2018 - 2030 (USD Million)
TABLE 35 Italy Glycomics Market, By Application, 2018 - 2030 (USD Million)
TABLE 36 Italy Glycomics Market, By End-Use, 2018 - 2030 (USD Million)
TABLE 37 Denmark Glycomics Market, By Product, 2018 - 2030 (USD Million)
TABLE 38 Denmark Glycomics Market, By Application, 2018 - 2030 (USD Million)
TABLE 39 Denmark Glycomics Market, By End-Use, 2018 - 2030 (USD Million)
TABLE 40 Norway Glycomics Market, By Product, 2018 - 2030 (USD Million)
TABLE 41 Norway Glycomics Market, By Application, 2018 - 2030 (USD Million)
TABLE 42 Norway Glycomics Market, By End-Use, 2018 - 2030 (USD Million)
TABLE 43 Sweden Glycomics Market, By Product, 2018 - 2030 (USD Million)
TABLE 44 Sweden Glycomics Market, By Application, 2018 - 2030 (USD Million)
TABLE 45 Sweden Glycomics Market, By End-Use, 2018 - 2030 (USD Million)
TABLE 46 Asia Pacific Glycomics Market, By Country, 2018 - 2030 (USD Million)
TABLE 47 Asia Pacific Glycomics Market, By Product, 2018 - 2030 (USD Million)
TABLE 48 Asia Pacific Glycomics Market, By Application, 2018 - 2030 (USD Million)
TABLE 49 Asia Pacific Glycomics Market, By End-Use, 2018 - 2030 (USD Million)
TABLE 50 China Glycomics Market, By Product, 2018 - 2030 (USD Million)
TABLE 51 China Glycomics Market, By Application, 2018 - 2030 (USD Million)
TABLE 52 China Glycomics Market, By End-Use, 2018 - 2030 (USD Million)
TABLE 53 Japan Glycomics Market, By Product, 2018 - 2030 (USD Million)
TABLE 54 Japan Glycomics Market, By Application, 2018 - 2030 (USD Million)
TABLE 55 Japan Glycomics Market, By End-Use, 2018 - 2030 (USD Million)
TABLE 56 India Glycomics Market, By Product, 2018 - 2030 (USD Million)
TABLE 57 India Glycomics Market, By Application, 2018 - 2030 (USD Million)
TABLE 58 India Glycomics Market, By End-Use, 2018 - 2030 (USD Million)
TABLE 59 South Korea Glycomics Market, By Product, 2018 - 2030 (USD Million)
TABLE 60 South Korea Glycomics Market, By Application, 2018 - 2030 (USD Million)
TABLE 61 South Korea Glycomics Market, By End-Use, 2018 - 2030 (USD Million)
TABLE 62 Australia Glycomics Market, By Product, 2018 - 2030 (USD Million)
TABLE 63 Australia Glycomics Market, By Application, 2018 - 2030 (USD Million)
TABLE 64 Australia Glycomics Market, By End-Use, 2018 - 2030 (USD Million)
TABLE 65 Thailand Glycomics Market, By Product, 2018 - 2030 (USD Million)
TABLE 66 Thailand Glycomics Market, By Application, 2018 - 2030 (USD Million)
TABLE 67 Thailand Glycomics Market, By End-Use, 2018 - 2030 (USD Million)
TABLE 68 Latin America Glycomics Market, By Country, 2018 - 2030 (USD Million)
TABLE 69 Latin America Glycomics Market, By Product, 2018 - 2030 (USD Million)
TABLE 70 Latin America Glycomics Market, By Application, 2018 - 2030 (USD Million)
TABLE 71 Latin America Glycomics Market, By End-Use, 2018 - 2030 (USD Million)
TABLE 72 Brazil Glycomics Market, By Product, 2018 - 2030 (USD Million)
TABLE 73 Brazil Glycomics Market, By Application, 2018 - 2030 (USD Million)
TABLE 74 Brazil Glycomics Market, By End-Use, 2018 - 2030 (USD Million)
TABLE 75 Mexico Glycomics Market, By Product, 2018 - 2030 (USD Million)
TABLE 76 Mexico Glycomics Market, By Application, 2018 - 2030 (USD Million)
TABLE 77 Mexico Glycomics Market, By End-Use, 2018 - 2030 (USD Million)
TABLE 78 Argentina Glycomics Market, By Product, 2018 - 2030 (USD Million),
TABLE 79 Argentina Glycomics Market, By Application, 2018 - 2030 (USD Million)
TABLE 80 Argentina Glycomics Market, By End-Use, 2018 - 2030 (USD Million)
TABLE 81 MEA Glycomics Market, By Country, 2018 - 2030 (USD Million)
TABLE 82 MEA Glycomics Market, By Product, 2018 - 2030 (USD Million)
TABLE 83 MEA Glycomics Market, By Application, 2018 - 2030 (USD Million)
TABLE 84 MEA Glycomics Market, By End-Use, 2018 - 2030 (USD Million),
TABLE 85 South Africa Glycomics Market, By Product, 2018 - 2030 (USD Million)
TABLE 86 South Africa Glycomics Market, By Application, 2018 - 2030 (USD Million)
TABLE 87 South Africa Glycomics Market, By End-Use, 2018 - 2030 (USD Million)
TABLE 88 UAE Glycomics Market, By Product, 2018 - 2030 (USD Million)
TABLE 89 UAE Glycomics Market, By Application, 2018 - 2030 (USD Million)
TABLE 90 UAE Glycomics Market, By End-Use, 2018 - 2030 (USD Million)
TABLE 91 Saudi Arabia Glycomics Market, By Product, 2018 - 2030 (USD Million),
TABLE 92 Saudi Arabia Glycomics Market, By Application, 2018 - 2030 (USD Million)
TABLE 93 Saudi Arabia Glycomics Market, By End-Use, 2018 - 2030 (USD Million)
TABLE 94 Kuwait Glycomics Market, By Product, 2018 - 2030 (USD Million)
TABLE 95 Kuwait Glycomics Market, By Application, 2018 - 2030 (USD Million)
TABLE 96 Kuwait Glycomics Market, By End-Use, 2018 - 2030 (USD Million)

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 世界のグライコミックス市場2023-2030：製品別（酵素、キット、試薬、機器）、用途別（創薬・開発、診断）、最終用途別、地域別(Glycomics Market Size, Share & Trends Analysis Report By Product (Enzymes, Kits, Reagents, Instruments), By Application (Drug Discovery & Development, Diagnostics), By End Use, By Region, And Segment Forecasts, 2023 - 2030)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • グリコミックスの世界市場2023-2030：市場規模、シェア、動向分析
  • 世界のマルチオミクス市場2023-2030：製品・サービス別（装置、消耗品）、種類別（シングルセル、バルク）、プラットフォーム別、用途別、最終用途別、地域別
  • 世界の細胞培養培地保存容器市場2023-2030：製品別（保存袋、保存瓶）、用途別（バイオ医薬品製造、診断）、最終用途別、地域別
  • 世界の細胞凍結保存市場2024-2030：製品別（細胞凍結培地、装置）、用途別（幹細胞、精子細胞）、最終用途別（バイオバンク、体外受精）、地域別
  • ガラス化のグローバル市場2023-2030：卵子、胚、精子

    • ◆H&Iグローバルリサーチのお客様（例）◆